New mRNA vaccine is more effective and less costly to develop A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, according to a new study.
https://www.sciencedaily.com/r....eleases/2025/06/2506

Large-scale immunity profiling grants insights into flu virus evolution A new study shows how person-to-person variation in antibody immunity plays a key role in shaping which influenza (flu) strains dominate in a population.
https://www.sciencedaily.com/r....eleases/2025/06/2506

Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes A research team has achieved a significant breakthrough in developing broadly protective, live-attenuated influenza vaccines (LAIV). These innovative LAIV platforms offer potential to develop universal influenza vaccines that induce a more robust immune response against various virus subtypes, including both human and avian strains.
https://www.sciencedaily.com/r....eleases/2025/05/2505

Engineering an antibody against flu with sticky staying power Scientists have engineered a monoclonal antibody that can protect mice from a lethal dose of influenza A, a new study shows. The new molecule combines the specificity of a mature flu fighter with the broad binding capacity of a more general immune system defender.
https://www.sciencedaily.com/r....eleases/2025/05/2505

Study reveals gaps in flu treatment for high-risk adults A multi-state study reveals that many high-risk adults diagnosed with influenza (flu) in emergency departments and urgent care centers are not receiving timely antiviral treatment. Researchers found that only slightly more than half of these patients received antiviral prescriptions, and of those, only 80 percent were filled. This gap in treatment could increase the risk of severe flu complications, particularly for older adults and those with underlying conditions.
https://www.sciencedaily.com/r....eleases/2025/04/2504